San Diego company testing artificial pancreas made from stem cells

San Diego's Viacyte is testing its artificial, lab-grown pancreas in three humans. The artificially derived pancreas cells are created using human stem cells and inserted into the subject through an incision in the back. In the hopes of treating diabetes, Medtronic ($MDT) and others are attempting to create a functional artificial pancreas using a mechanical approach. But Viacyte hopes the use of stem cells will enable it to create a truly artificial pancreas. Article

Suggested Articles

InterVene secured $15 million to validate its catheter-based treatment for correcting failed one-way valves in the veins of the legs.

LabCorp, Philips and Mount Sinai are coming together to develop an AI-driven pathology center of excellence, aimed initially at cancer diagnosis.

The FDA followed through with plans to end its Alternative Summary Reporting program, making 20 years’ worth of device safety data publicly available.